H100 Group ABNGM:H100 +0.91%33 ROE % is 0.00% as of Dec. 2025. GuruFocus rates NGM:H100 with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 624 Healthcare Providers & Services companies, H100 Group AB ranks worse than 73.56% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. H100 Group AB's annualized net income for the quarter that ended in Dec. 2025 was kr0.00 Mil. H100 Group AB's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was kr460.22 Mil. Therefore, H100 Group AB's annualized ROE % for the quarter that ended in Dec. 2025 was 0.00%.
The historical rank and industry rank for H100 Group AB's ROE % or its related term are showing as below:
NGM:H100'
s ROE % Range Over the Past 10 Years
Min: -39.2 Med: -14.3 Max: 10.44
Current: -3.56
During the past 8 years, H100 Group AB's highest ROE % was 10.44%. The lowest was -39.20%. And the median was -14.30%.
NGM:H100's ROE % is ranked worse than 73.56% of 624
companies
in the Healthcare Providers & Services industry
Industry Median: 5.85
vs NGM:H100: -3.56
H100 Group AB (NGM:H100) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
H100 Group AB ROE % Related Terms
H100 Group AB ROE % Historical Data
* Premium members only.
The historical data trend for H100 Group AB's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, H100 Group AB's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H100 Group AB ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, H100 Group AB's ROE % distribution charts can be found below:
* The bar in red indicates where H100 Group AB's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
H100 Group AB (NGM:H100) has a ROE % of 0.00% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on H100 Group AB and its competitors. According to the industry distribution chart, H100 Group AB ranks #459 out of 624 companies in the Healthcare Providers & Services industry, placing it in the top 73.6%.
Is H100 Group AB's ROE % too high?
H100 Group AB's current ROE % is 0.00%. Based on the distribution chart, H100 Group AB ranks #459 out of 624 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, H100 Group AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does H100 Group AB's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, H100 Group AB ranks #459 out of 624 companies for ROE %. This places H100 Group AB in the lower half of its industry. The industry median ROE % is 5.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.85, based on 624 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on H100 Group AB and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H100 Group AB's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H100 Group AB stock overvalued right now?
H100 Group AB (NGM:H100) has a current ROE % of 0.00%. The current ROE % is 0.00%. H100 Group AB's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For H100 Group AB (NGM:H100), the current ROE % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
H100 Group AB is a Swedish health technology company and the Bitcoin Treasury Company in the Nordics. The Company's objective is to maximize Bitcoin exposure per share by expanding its Bitcoin treasury through financial instruments. The Company operates through two business areas: Bitcoin Treasury operations, which focus on increasing Bitcoin exposure per share through strategic and financial instruments, and a health-tech division that supports health and longevity providers with AI-powered automation and growth tools. The Company generates revenue from digital services related to training and nutrition coaching provided to B2C customers and SaaS revenue related to the Group's digital platform provided to B2B customers. It operates in Sweden and Norway.
33GF Score
Get the complete analysis for NGM:H100
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:H100 has been successfully added to your 
